Related Experiment Video
Updated: Mar 2, 2026

Spontaneous Murine Model of Anaplastic Thyroid Cancer
Published on: February 3, 2023
[PAPILLARY THYROID CARCINOMA TREATMENT - IS THE PENDULUM SHIFTING?]
Sagit Stern1,2, Elad Dagan3,2, Eran E Alon3,2
1Department of Otolaryngology Head and Neck Surgery, Rabin Medical Center, Petach Tikva, Israel.
Prophylactic central neck dissection for papillary thyroid carcinoma is debated. While it finds many positive lymph nodes, its impact on survival versus surgical risks requires further study.
Area of Science:
- Oncology
- Surgical Oncology
Background:
- Papillary thyroid carcinoma incidence is increasing, yet mortality remains stable.
- Occult lymph node metastasis is found in 60% of cases during prophylactic central neck dissection (level 6).
- Current guidelines for prophylactic central neck dissection vary globally due to limited randomized controlled trials.
Purpose of the Study:
- To review evidence supporting and opposing prophylactic central neck dissection in papillary thyroid carcinoma patients.
- To evaluate the balance between potential benefits and surgical morbidity associated with the procedure.
Main Methods:
- Literature review of existing studies on prophylactic central neck dissection for papillary thyroid carcinoma.
- Exploration of data regarding lymph node metastasis rates and surgical outcomes.
Main Results:
- High rates of occult lymph node metastasis (60%) justify the procedure for some.
- Concerns exist regarding increased surgical morbidity without a clear impact on disease-specific mortality.
Conclusions:
- The effectiveness and necessity of prophylactic central neck dissection for papillary thyroid carcinoma remain controversial.
- Further research, particularly randomized controlled trials, is needed to establish definitive guidelines.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Tumor Immunotherapy
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Treatment Strategies for Psychological Disorders
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...

